<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4931293 Figure_1-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A CUEDC2protein levels in mouse tissues. Adult (12-week-old) mouse was sacrifices and total protein was extracted from the liver, kidney, lung, spleen, heart, stomach, intestine, prostate, testis, brain, and thymus.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_1-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B (top) In vivo cardiac ischemia-reperfusion model protocol (30-minute ischemia followed by indicated times of reperfusion). (bottom) Mice were subjected to reversible ischemia in vivo for 30 minutes and reperfused for different time period. Protein was extracted from the area at risk of heart at the indicated time points and subjected to immunoblot analysis of CUEDC2 and CUEDC1. Representative results were shown from 2 mice at each time point, and experiments were repeated for three times.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_1-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Isolated primary rat neonatal cardiomyocytes were treated to hypoxia with serum free-medium for 6h and reoxygenated accompanying adding serum back for different time period in vitro and the protein level of CUEDC2 was tested at different time points during reoxygenation. Each experiment was repeated for three times.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_1-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D CUEDC2 protein level was plotted using the immunohistochemical scores as described in methods. (left) Plot of CUEDC2 scores in each BZ and DZ (n = 9 patients). (right) Representative images from immunohistochemistry staining for CUEDC2 in tissues from patients who suffered acute myocardial infarctions. The boxed areas in the left images are magnified in the middle and right images. DZ, distant zone; BZ, border zone. Scale bars, 250 &#956;m (left), 50 &#956;m (middle and right). * p = 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_2-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Primary mouse cardiomyocytes were treated with H2O2 (1 mM) for 3 hours and cardiomyocyte viability was determined by flow cytometry. Representative results of flow cytometry analysis.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_2-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Quantitative analysis of PI-positive cells treated with H2O2 was shown (42.9 &#177; 3.1% in wild-type group vs. 10.1 &#177; 4.4% in Cuedc2-/- group, * p = 0.0004, n = 5 wells per group and repeated for three times).</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_2-C-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Mouseneonatal cardiomyocytes were subjected to hypoxia for 6 hours and then reoxygenation for 30 minutes. Cardiomyocytes were then stained with 5 &#956;M CellROX&#174; Deep Red Reagent and analyzed by flow cytometry. Representative results of flow cytometry analysis are shown, and all experiments were repeated for three times. D ROS levels were quantitated and summarized. * p = 0.0108, n = 3 wells per group and repeated for three times.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_2-E-F</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E HPLC detection of a superoxide probe oxidized dihydroethidium (DHE) product in sham and I/R injury heart tissue (30-min ischemia followed by 30-min reperfusion), 2-hydroxyethidium (EOH), a specific product for superoxide anion radical. *p &lt; 0.0001, n = 5 in each group. F In the same samples of (E), HPLC detection of ethidium (E), oxidized by other reactive oxygen species such as H2O2 (mainly) and ONOO. *p = 0.0001, n = 5 in each group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_3-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Protein was extracted from the area at risk of left ventricle from wild-type or Cuedc2-/- mice with 30-minute ischemia followed by 30-minute reperfusion and subjected to immunoblot analysis. Representative results from 2 mice are shown, and each experiment was repeated for three times.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_3-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Neonatal mouse cardiomyocytes were subjected to hypoxia for 6 hours, followed by the indicated times of reoxygenation, before protein was extracted and subjected to immunoblot analysis.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_3-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Luciferase assay of WT or Cuedc2-/- MEFs transiently transfected with an NF-&#954;B-responsive luciferase reporter and then, 1 d later, treated for 6 h with TNF (10 ng/ml; TNF) or for H/R. * p = 0.0032, n = 3 per group, ** p = 0.013, n = 3 per group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_3-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Wild-type and Cuedc2-/- mice were treated with a sham or I/R operation in vivo. Three hours after the onset of reperfusion, the mRNA levels of tumor necrosis factor &#945; (TNF&#945;), interleukin 6 (IL-6) and interleukin 23 (IL-23) were tested. * p = 0.0005, ** p = 0.0001, n = 3 per group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Protein was extracted from the left ventricle of wild-type or Cuedc2-/- adult mice (12 week-old) and subjected to immunoblot analysis (3 mice per group).</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Wild-type or Cuedc2-/- mice were subjected to a heart ischemia for 30-minute in vivo, followed by reperfusion for the indicated times. Protein was extracted from the area at risk of left ventricle and subjected to immunoblot analysis.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C GPX1 protein level was plotted using the immunohistochemical scores as described in methods. (left) representative images from immunohistochemistry staining for GPX1 in tissues from patients who suffered acute myocardial infarctions. (right) plot of GPX1 scores in each BZ and DZ (n = 9 patients). DZ, distant area; BZ, border zone. Scale bars, 250 &#956;m (left). * p = 0.0039.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Primary neonatal mouse cardiomyocytes stably expressing control or GPX1 shRNA by lentivirus infection were treated with H2O2 (1 mM) for 3 hours. Cell viability was detected by FACS. * p = 0.0001; ** p = 0.0275, n = 3 wells per group. NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-E</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Primary neonatal mouse cardiomyocytes were transfected with lentivirus carrying control or GPX1 shRNA, and the efficiency of GPX1 knockdown was tested by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_4-F</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Primary neonatal mouse cardiomyocytes stably expressing control or GPX1 shRNA by lentivirus infection were subjected to H2O2 (1 mM) for 30 minutes and then stained with 5 &#956;M CellROX&#174; Deep Red Reagent and analyzed by flow cytometry. * p = 0.0056; ** p = 0.0218, n = 3 wells per group, n = 3 wells per group. NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_5-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Lysates from MEF-WT or MEF-Cuedc2-/- cells treated with 20&#956;M cycloheximide (CHX) for the indicated times were subjected to immunoblotting (left). Relative GPX1 levels were quantified by densitometry (right).</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_5-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B MEF-Cuedc2-/- cells were transfected with increasing amounts of FLAG-CUEDC2 (mouse) plasmids (1 &#956;g and 2 &#956;g). At 24 hours after transfection, the cells were treated with the proteasome inhibitor MG-132 (10 &#956;M). Cells were cultured for additional 6 hours and subjected to immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_5-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HEK293T cells were transfected with the FLAG-GPX1, HA-CUEDC2, and Myc-ubiquitin plasmids as indicated and treated with MG-132 (10 &#181;M) for 6 hours before harvest. Cell lysates were immunoprecipitated (IP) with anti-FLAG (M2). The immunoprecipitates were analyzed by western blot using an anti-GPX1 antibody. Whole-cell lysates (WCL) were analyzed by Western blots with anti-FLAG or anti-HA antibody to determine the protein of Flag-GPX1 and HA-CUEDC2.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_5-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D The heart tissue lysates from wide-type and Cuedc2-/- mice were incubated with IgG or anti-GPX1 antibody, and then captured on protein G-Sepharose beads. The immunoprecipitates were analyzed by immunoblotting with an anti-ubiquitin antibody.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_5-E</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E HEK293T cells were transfected with the Flag-CUEDC2 or Flag-CUEDC2&#9651;CUE (deletion of the CUE domain of CUEDC2), and treated with MG-132 (10 &#181;M) for 6 hours before harvest. Cell lysates were immunoprecipitated (IP) with anti-Flag (M2). The immunoprecipitates were analyzed by western blot using an anti-GPX1 antibody. Whole-cell lysates (WCL) were analyzed by Western blots with anti-Flag or anti-GPX1 antibody to determine the protein of Flag-CUEDC2 and GPX1. v: vector.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_6-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HEK293 cells were transfected with increasing amounts of Flag-TRIM33 expression vectors and 48 hours after transfection, cell lysates were subjected to immunoblotting (IB) using antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_6-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HEK293 cells were transfected with increasing amounts of Flag-FBXW7 expression vectors and 48 hours after transfection, cell lysates were subjected to immunoblotting (IB).</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_6-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HEK293T cells were transfected as indicated, at 18 h after transfection, the cells were treated with the proteasome inhibitor MG132 (20&#956;M) for 6 hours and then harvested. Cell lysates were immunoprecipitated by Flag-antibody (M2 beads) and Ubiquitin-conjugated GPX1 was detected by Western blotting with anti-Myc antibody.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_6-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D HEK293 cells were transfected with either control or CUEDC2 siRNA and increasing amounts of Flag-TRIM33 expression vectors, cell lysates were subjected to immunoblotting (IB) using antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_7-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A CUEDC2 ablation reduced I/R injury, which was induced by 30 minutes of ischemia followed by 24 hours reperfusion. AAR, area at risk; LV, left ventricular area, IRI, area of I/R injury. The ratios of AAR to LV, IRI to AAR and IRI to LV are shown. * p &lt; 0.0001 compared with WT, n = 15 mice per group. (top panel) Representative cross-sectional slices derived from the hearts stained by TTC. Area of I/R injury is indicated in light pink.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_7-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Representative images of ventricular myocardium sections from WT and Cuedc2-/- mice exposed to sham operation or I/R injury (2 hours after the onset of reperfusion following 30-min ischemia). Green, TUNEL-positive myocytenuclei; red, Troponin I-stained cardiomyocytes; blue, DAPI-stained nuclei. Scale bar, 50 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_7-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Quantitative analysis of apoptosis. * p &lt; 0.0001, n = 8 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_7-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D SerumLDH levels in sham-operated mice or those subjected to ischemia and a 4-hour reperfusion. Data from 3 separate experiments was analyzed by one-way analysis of variance. * p &lt; 0.0001, n = 13 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_7-E</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Echocardiography analysis of left ventricular dimensions and cardiac function at 1 week post-I/R in mice. ** p &lt; 0.0001, n = 15 mice in the sham-operated group and n = 10 mice in the I/R group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_8-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunoblotting for CUEDC2 protein level. 4 weeks after tail-vein injection of rAAV9-CUEDC2, indicated mice tissues were harvested and subjected to immunoblotting to detect CUEDC2 protein level. Ctl: heart of rAAV9-GFP injected mice.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_8-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Animals were injected by rAAV9-CUEDC2 in a different amount of viral genomes (VG). Heart tissues were then analyzed by immunoblotting to detect CUEDC2 transduction. Tubulin protein level was examined for normalization purposes.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_8-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C The ratios of AAR to LV, IRI to AAR and IRI to LV are shown. n = 10 mice in WT + rAAV-GFP group and Cuedc2-/- + rAAV-GFP group; n = 12 mice in Cuedc2-/- + rAAV-CUEDC2 (1&#215;1010 VG) group and Cuedc2-/- + rAAV-CUEDC2 (1&#215;1011 VG) group. * p = 0.0055, ** p = 0.0146, *** p = 0.0200, **** p = 0.0377.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_8-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Effect of rAAV9-CUEDC2 treatment on echocardiography indices of left ventricle function recovery post-I/R measured by fractional shortening (FS) and ejection fraction (EF). WT+ rAAV-GFP (n = 10); Cuedc2-/- + rAAV-GFP (n = 10); Cuedc2-/- + rAAV-CUEDC2 (Low dose) (n = 12); Cuedc2-/- + rAAV-CUEDC2 (High dose) (n = 12). ** p &lt; 0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-A</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HPLC detection of a superoxide probe oxidized dihydroethidium (DHE) product in young (8-week-old) and old mouse (20-month-old) heart tissue, 2-hydroxyethidium (EOH), a specific product for superoxide anion radical. * p = 0.0087, n = 5 in each group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-B</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HPLC detection of ethidium (E), oxidized by other reactive oxygen species such as H2O2 (mainly) and ONOO. * p = 0.0021, n = 5 in each group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-C</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in young and old mice. * p = 0.0164, n = 6 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-D</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Comparison of heart weight / body weight (HW/BW) in WT and Cuedc2-/- mice. ** p = 0.036, n = 15 in young WT and Cuedc2-/- mice, n = 10 in old WT mice and n = 12 in old Cuedc2-/- mice.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-E</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Comparison of the left ventricle function in WT and Cuedc2-/- mice by transthoracic echocardiography. *p = 0.0384, **p = 0.0389. n = 15 in young WT and Cuedc2-/- mice, n = 10 in old WT mice and n = 12 in old Cuedc2-/- mice.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-F</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-F</infon>
    <infon key="sourcedata_figure_dir">Figure_9-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Left ventricle cardiomyocytes apoptosis was tested by TUNEL staining. *p = 0.0017, n = 5 in each group.</text>
    </passage>
  </document>
  <document>
    <id>4931293 Figure_9-G-H</id>
    <infon key="sourcedata_document">1958</infon>
    <infon key="doi">10.15252/emmm.201506010</infon>
    <infon key="pmc_id">4931293</infon>
    <infon key="figure">Figure 9-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_9-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G Left ventricle myocardial fibrosis was tested by Masson staining in WT and Cuedc2-/- mice. The represent results were shown in (G) and the quantitative analysis of myocardial fibrosis was shown in (H). *p = 0.0177, n = 5 in each group.</text>
    </passage>
  </document>
</collection>
